Historical record - last NADAC effective date: 2/22/2017
Product Information
RAMIPRIL 1.25 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1792 per EA under NDC 65862047430. Its NADAC has been published 170 times since Nov 28, 2013.
FDA first approved this application on Jun 8, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Ramipril market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1.25 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862047430
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
2/22/2017
Active Ingredients
RAMIPRILApproval Type
Generic (ANDA)
FDA Application
ANDA091604FDA Approved
6/8/2011
TE Code
AB
On Market Since
6/8/2011
Pharmacological Classes
Price Statistics
The NADAC for RAMIPRIL 1.25 MG CAPSULE has been published 170 times since Nov 28, 2013, and over the history we have for it it has declined 15.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1792 per EA |
|---|---|
| All-time high | $0.2323 (Aug 13, 2014) |
| All-time low | $0.1542 (Jan 18, 2017) |
| Median price | $0.1970 |
| Average price | $0.1957 |
| Largest weekly change | +33.5% (Jan 20, 2016) |
| Weeks tracked | 170 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-15.6%
Last surveyed Feb 22, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 55% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ramipril market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin Converting Enzyme Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RAMIPRIL 1.25 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RAMIPRIL 1.25 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.1792 per EA (NDC 65862047430), effective Feb 22, 2017.
How has the price of RAMIPRIL 1.25 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RAMIPRIL 1.25 MG CAPSULE has declined 15.6%. It has been tracked across 170 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for RAMIPRIL 1.25 MG CAPSULE?
Since Nov 28, 2013, the NADAC for RAMIPRIL 1.25 MG CAPSULE has ranged from a low of $0.1542 (Jan 18, 2017) to a high of $0.2323 (Aug 13, 2014), with a median of $0.1970 per EA.
Are there cheaper alternatives to RAMIPRIL 1.25 MG CAPSULE?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RAMIPRIL 1.25 MG CAPSULE, is $0.0804 per EA — about 55% below RAMIPRIL 1.25 MG CAPSULE.
Who manufactures RAMIPRIL 1.25 MG CAPSULE?
RAMIPRIL 1.25 MG CAPSULE (NDC 65862047430) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.